newsfilter
← Latest News
Business Wire·

Sierra Oncology to Present at Three September Investor Conferences

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer, today announced the company will participate in three investor conferences in September 2021. Stephen